Moderna, Inc. vs Sezzle Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Sezzle Inc trades at $179.07 (market cap $5.78B). The key difference: Moderna, Inc. is far larger — about 4.1× Sezzle Inc's market cap, and Sezzle Inc is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | SEZL | |
|---|---|---|
Market Cap | $23.60B | $5.78B |
Sector | Health | Technology |
52-Week High | $81.80 | $188.55 |
52-Week Low | $22.36 | $50.97 |
Enterprise Value | $19.70B | $5.80B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →